FY2025 EPS Estimates for Core Laboratories Inc. Decreased by Zacks Research (NYSE:CLB)

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research lowered their FY2025 EPS estimates for Core Laboratories in a research report issued to clients and investors on Thursday, April 18th. Zacks Research analyst T. Saha now forecasts that the oil and gas company will post earnings per share of $0.94 for the year, down from their previous estimate of $0.95. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share.

A number of other equities research analysts have also commented on the stock. Stifel Nicolaus dropped their price objective on shares of Core Laboratories from $21.00 to $17.00 and set a “hold” rating on the stock in a report on Monday, February 5th. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, January 20th. Finally, Bank of America dropped their price objective on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating on the stock in a report on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.50.

Core Laboratories Trading Up 0.2 %

Shares of NYSE:CLB opened at $17.00 on Monday. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $27.94. The company has a quick ratio of 1.72, a current ratio of 2.53 and a debt-to-equity ratio of 0.71. The company’s fifty day simple moving average is $16.20 and its 200 day simple moving average is $17.68. The firm has a market cap of $796.62 million, a price-to-earnings ratio of 19.77, a PEG ratio of 0.97 and a beta of 2.40.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, January 31st. The oil and gas company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.01). The firm had revenue of $128.21 million during the quarter, compared to analyst estimates of $127.80 million. Core Laboratories had a return on equity of 15.19% and a net margin of 8.03%. During the same quarter last year, the business posted $0.23 earnings per share.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Allspring Global Investments Holdings LLC bought a new position in Core Laboratories in the third quarter valued at $31,000. GAMMA Investing LLC bought a new position in Core Laboratories in the fourth quarter valued at $48,000. Quadrant Capital Group LLC grew its position in Core Laboratories by 84.0% in the fourth quarter. Quadrant Capital Group LLC now owns 3,370 shares of the oil and gas company’s stock valued at $60,000 after purchasing an additional 1,538 shares in the last quarter. CWM LLC grew its position in Core Laboratories by 1,178.6% in the first quarter. CWM LLC now owns 3,580 shares of the oil and gas company’s stock valued at $61,000 after purchasing an additional 3,300 shares in the last quarter. Finally, Platinum Investment Management Ltd. grew its position in Core Laboratories by 43.8% in the fourth quarter. Platinum Investment Management Ltd. now owns 5,577 shares of the oil and gas company’s stock valued at $98,000 after purchasing an additional 1,698 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 4th. Investors of record on Monday, February 12th were given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend was Friday, February 9th. Core Laboratories’s dividend payout ratio (DPR) is currently 4.65%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.